Terminology Service < Semantic Lookup Platform

All terms in ONE

Label	Id	Description
mortal cell line	CLO_0009829	[A cell line is able to support only a limited number of passages in vitro.]
vaccine	VO_0000001	[A vaccine is a processed material with the function that when administered, it prevents or ameliorates a disorder in a target organism by inducing or modifying adaptive immune responses specific to the antigens in the vaccine.]
loop design	OBI_0500009	[A loop experiment design is where labeled extracts are compared in consecutive pairs. synonym: circular design]
parameter threshold	OBI_0000172	[A measurement datum measuring the minimal signal that must be detected to generate an electrical event, as compared to the maximal detected signal in a flow cytometer instrument. The datum has a qualitative role]
balanced incomplete block design	OBI_0500008	[balanced incomplete block design is a kind of factorial design where all treatment pairs occur together within a block an equal number ?? times. ??ii' is the number of times treatment i occurs with i']
factorial design	OBI_0500014	[factorial design is_a study design which is used to evaluate two or more factors simultaneously. The treatments are combinations of levels of the factors. The advantages of factorial designs over one-factor-at-a-time experiments is that they are more efficient and they allow interactions to be detected. In statistics, a factorial design experiment is an experiment whose design consists of two or more factors, each with discrete possible values or levels, and whose experimental units take on all possible combinations of these levels across all such factors. Such an experiment allows studying the effect of each factor on the response variable, as well as the effects of interactions between factors on the response variable.]
autotransplantation	OBI_0000171	[is the transplantation of tissue from one part of \nthe body to another in the same individual. )]
randomized complete block design	OBI_0500007	[A randomized complete block design is_a study design which assigns randomly treatments to block. The number of units per block equals the number of treatment so each block receives each treatment exactly once (hence the qualifier 'complete'). The design was originally devised from field trials used in agronomy and agriculture. The analysis assumes that there is no interaction between block and treatment. The method was then used in other settings So The randomised complete block design is a design in which the subjects are matched according to a variable which the experimenter wishes to control. The subjects are put into groups (blocks) of the same size as the number of treatments. The members of each block are then randomly assigned to different treatment groups.]
parallel group design	OBI_0500006	[A parallel group design or independent measure design is a study design which uses unique experimental unit each experimental group, in other word no two individuals are shared between experimental groups, hence also known as parallel group design. Subjects of a treatment group receive a unique combination of independent variable values making up a treatment]
vaccination	VO_0000002	[a process of administering substance in vivo that involves in adding a vaccine into a host (e.g., human) in vivo with the intent to invoke a protective or therapeutic adaptive immune response.]
matched pairs design	OBI_0500005	[A matched pair design is a study design which use groups of individuals associated (hence matched) to each other based on a set of criteria, one member going to one treatment, the other member receiving the other treatment.]
pathogen	IDO_0000528	[A material entity with a pathogenic disposition.]
n-to-1 design	OBI_0500004	[N-of-1 design is a cross-over design in which the same patient is repeatedly randomised to receive either the experimental treatment or its control (Senn, 1993).]
cross over design	OBI_0500003	[a repeated measure design which ensures that experimental units receive, in sequence, the treatment (or the control), and then, after a specified time interval (aka wash-out periods), switch to the control (or treatment). In this design, subjects (patients in human context) serve as their own controls, and randomization may be used to determine the ordering which a subject receives the treatment and control]
repeated measure design	OBI_0500002	[a study design which use the same individuals and exposure them to a set of conditions. The effect of order and practice can be confounding factor in such designs]
clinical study design	OBI_0500001	[Plan for the precise procedure to be followed in a clinical trial, including planned and actual timing of events, choice of control group, method of allocating treatments, blinding methods; assigns a subject to pass through one or more epochs in the course of a trial. Specific design elements, e.g., crossover, parallel; dose-escalation [Modified from Pocock, Clinical Trials: A Practical Approach]]
FFPE specimen	OBI_1200000	[A specimen that has been fixed in formalin and embedded in paraffin.]
transforming growth factor beta2 production	GO_0032906	[The appearance of transforming growth factor-beta2 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.]
transforming growth factor beta1 production	GO_0032905	[The appearance of transforming growth factor-beta1 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.]
transforming growth factor beta3 production	GO_0032907	[The appearance of transforming growth factor-beta3 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.]